PE Tech Report

NEWSLETTER

Like this article?

Sign up to our free newsletter

Avista-backed Cosette Pharmaceuticals acquires of G&W Laboratories’ finished dosage manufacturing plant

Avista-backed Cosette Pharmaceuticals acquires of G&W Laboratories’ finished dosage manufacturing plant.

Cosette Pharmaceuticals, a generic pharmaceutical company focused on extended topical and suppository products and portfolio company of Avista, has purchased G&W Laboratories’ finished dosage manufacturing plant located in Lincolnton, NC.
 
“The purchase of the Lincolnton plant expands Cosette’s capabilities into new dosage forms while simultaneously allowing us to enter a new business vertical that complements our overall growth strategy,” says Walt Kaczmarek, President and Chief Executive Officer of Cosette. “The Lincolnton facility has an excellent track record of producing liquid pharmaceuticals along with other differentiated dosage forms, and operates as a contract manufacturer across multiple presentations for select business partners. 
 
“We look forward to integrating their expertise and capabilities to the Cosette family and adding value to the Cosette growth pathway.”

Like this article? Sign up to our free newsletter

MOST POPULAR

FURTHER READING

Featured